Suppr超能文献

维生素D与视网膜母细胞瘤。受体的存在及体外生长抑制。

Vitamin D and retinoblastoma. The presence of receptors and inhibition of growth in vitro.

作者信息

Saulenas A M, Cohen S M, Key L L, Winter C, Albert D M

机构信息

Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston 02114.

出版信息

Arch Ophthalmol. 1988 Apr;106(4):533-5. doi: 10.1001/archopht.1988.01060130579041.

Abstract

The vitamin D receptor has been found in several human organs not involved in calcium metabolism and in several malignant neoplasms found in humans. The role of the receptor in these tissues is unclear. There is, however, a relationship between the presence and quantity of the vitamin D receptor in a malignant cell line and the antineoplastic effect of vitamin D on that cell line. We found that Y-79 retinoblastoma cells have receptors specific for calcitriol (1,25-dihydroxycholecalciferol). Scatchard analysis of the receptor data shows a quantity of 56,000 receptors per retinoblastoma cell. These receptors have a dissociation constant of 1.18 nmol/L. Retinoblastoma cells treated with 10(-9) mol/L of calcitriol for nine days had 15% less cell growth than the control cells. Further studies of the effect of vitamin D on retinoblastoma may warrant its inclusion in chemotherapeutic protocols for the treatment of this childhood affliction.

摘要

维生素D受体已在人体中一些不参与钙代谢的器官以及几种人类恶性肿瘤中被发现。该受体在这些组织中的作用尚不清楚。然而,恶性细胞系中维生素D受体的存在和数量与维生素D对该细胞系的抗肿瘤作用之间存在关联。我们发现Y-79视网膜母细胞瘤细胞具有对骨化三醇(1,25-二羟基胆钙化醇)特异的受体。对受体数据进行Scatchard分析显示,每个视网膜母细胞瘤细胞有56,000个受体。这些受体的解离常数为1.18 nmol/L。用10(-9) mol/L骨化三醇处理9天的视网膜母细胞瘤细胞的生长比对照细胞少15%。对维生素D对视网膜母细胞瘤影响的进一步研究可能使其有必要被纳入治疗这种儿童疾病的化疗方案中。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验